To test anti-tumor proliferative capacity, we performed Hematoxylin and Eosin (H&E) staining, immunohistochemistry (IHC), and immunofluorescence (IF) staining on 4T1 tumor tissues after treatment to examine the cell apoptosis, proliferation marker (Ki67) and endothelial lining vascular marker (CD34). Here, MKI67 is linked to neoplasm.